Trials / Suspended
SuspendedNCT02381106
The ADRB3 Receptor in Pregnancy
The ADRB3 Adrenergic Receptor - a Possible New Target for Controlling Pre-eclampsia and Hypertension in Pregnancy and Uterine Contractions in Non-pregnant and Pregnant Myometrium
- Status
- Suspended
- Phase
- —
- Study type
- Observational
- Enrollment
- 80 (estimated)
- Sponsor
- Karolinska Institutet · Academic / Other
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The primary overall objective of this study is to characterize the levels of and compare levels of the ADRB3 receptor in human non-pregnant myometrium, pregnant myometrium at different time points in pregnancy, in normal and dysfunctional labor and also to measure levels and expression of these receptors in placental arteries at different maturation statuses of placenta and in pre-eclampsia/hypertension
Conditions
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2028-12-01
- Completion
- 2029-12-01
- First posted
- 2015-03-06
- Last updated
- 2023-05-17
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT02381106. Inclusion in this directory is not an endorsement.